Article Text

Download PDFPDF
Insights into the prognostic significance of thrombus composition in cancer related stroke after thrombectomy
  1. Yi Huang1,
  2. Yingquan Ye2,
  3. Lingling Bao3,
  4. Xuefan Zeng4,
  5. Zhixiang Chen1
  1. 1Wuhu Hospital of Traditional Chinese Medicine, Wuhu, Anhui, China
  2. 2The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
  3. 3Zhejiang University School of Medicine First Affiliated Hospital Beilun Branch, Ningbo, Zhejiang, China
  4. 4Chongqing Medical University, Chongqing, China
  1. Correspondence to Dr Zhixiang Chen; 13956202494{at}163.com; Dr Xuefan Zeng; zxfcqmu{at}163.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with great interest the recent article by Fu et al.1 The study provides valuable insights into the role of thrombus composition in predicting clinical outcomes among cancer patients who underwent endovascular thrombectomy for acute ischemic stroke. We commend the authors for their comprehensive analysis and thoughtful discussion on this important topic.

Key findings and clinical relevance

The study’s primary outcome, defined as any stroke recurrence or mortality within 90 days after the index stroke event, is of significant clinical relevance. The finding that patients with active cancer showed a higher rate of the primary outcome is consistent with previous literature highlighting …

View Full Text

Footnotes

  • YH and XZ contributed equally.

  • Correction notice Since this letter first published, the author surname Cheng has been updated to Chen.

  • Contributors ZC is the guarantor of this work. XZ and ZC are the corresponding authors. All authors contributed to this letter.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles